Search - tctmd.com

Displaying 1 - 20 of 75

Sort: Relevancy | Date

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

February 28, 2024

Presentation ACC 2023

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Presenter: John K. Forrest

March 05, 2023

Presentation TVT 2020

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Presenter: Bruce Rutkin

June 20, 2020

Presentation Live Valves 2019

All Trileaflet AS (even low risk) Should be Treated with TAVI

Presenter: Vinod H. Thourani

December 10, 2019

Presentation Live Valves 2019

All AS Patients ( incl. Low-Risk) should be treated with TAVI

Presenter: Christian W. Hamm

December 10, 2019

Presentation CACI 2019

TAVI in Low Risk Patients

Presenter: Fayaz Shawl

November 29, 2019

Presentation CACI 2019

¿Es posible tratar bajo riesgo en Argentina?

Presenter: Daniel Berrocal

November 29, 2019

Presentation Cardiovascular Interventions 2019

Show me the Data: Key Clinical Trials of 2019

Presenter: Ehtisham Mahmud

November 01, 2019

Presentation TCT Abstracts Posters 2019

Experience of Implantation of New Generation Self-expandable Transcatheter Aortic Valve Implantation in Patients with Low Surgical Risk

Presenter: Harol Hernández

October 13, 2019

Presentation TCT Abstracts Posters 2019

Transcatheter Aortic Valve Replacement in Low-risk Patients A Meta-analysis of Randomized Controlled Trials

Presenter: Ahmad Al-Abdouh

October 06, 2019

Presentation TCT Abstracts Posters 2019

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Presenter: Yuichi Ozaki

September 29, 2019

Presentation ARCH 2019

Management of CAD and Aortic Stenosis: Current Thought on the Low Risk Patient

Presenter: Marc A. Sintek

April 11, 2019

Presentation SIF 2019

My Prediction on TAVR in Low Risk Patients

Presenter: Kendra J. Grubb

March 30, 2019

Presentation CIT 2019

Status of indication of TAVR versus SAVR in low-intermediate risk patients

Presenter: Thomas Modine

March 28, 2019

Presentation ACC 2019

Primary Results From the Evolut Low Risk Trial

Presenter: Michael J. Reardon

March 17, 2019

Presentation ACC 2019

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Presenter: Martin B. Leon

March 17, 2019

Presentation CRT 2019

Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis

Presenter: Ron Waksman

March 05, 2019

Presentation

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

February 06, 2019

Bioprosthetic structural valve degeneration

Presentation CDM 2018

TAVR is Here to Stay: What About TAVR in Low-Risk Patients?

Presenter: Joseph P. Carrozza

October 12, 2018

Advertisement

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

All Trileaflet AS (even low risk) Should be Treated with TAVI

All AS Patients ( incl. Low-Risk) should be treated with TAVI

TAVI in Low Risk Patients

¿Es posible tratar bajo riesgo en Argentina?

Show me the Data: Key Clinical Trials of 2019

Experience of Implantation of New Generation Self-expandable Transcatheter Aortic Valve Implantation in Patients with Low Surgical Risk

Transcatheter Aortic Valve Replacement in Low-risk Patients A Meta-analysis of Randomized Controlled Trials

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Management of CAD and Aortic Stenosis: Current Thought on the Low Risk Patient

My Prediction on TAVR in Low Risk Patients

Status of indication of TAVR versus SAVR in low-intermediate risk patients

Primary Results From the Evolut Low Risk Trial

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

TAVR is Here to Stay: What About TAVR in Low-Risk Patients?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content